Hypoglycemia-associated autonomic failure in diabetes

Philip E. Cryer

Research output: Contribution to journalShort surveypeer-review

118 Scopus citations


Hypoglycemia is the limiting factor in the glycemic management of diabetes. The concept of hypoglycemia-associated autonomic failure (HAAF) in diabetes posits that recent antecedent iatrogenic hypoglycemia causes both defective glucose counterregulation (by reducing the epinephrine response to falling glucose levels in the setting of an absent glucagon response) and hypoglycemia unawareness (by reducing the autonomic and the resulting neurogenic symptom responses) and thus a vicious cycle of recurrent hypoglycemia. Perhaps the most compelling support for HAAF is the finding that as little as 2-3 wk of scrupulous avoidance of hypoglycemia reverses hypoglycemia unawareness and improves the reduced epinephrine component of defective glucose counterregulation in most affected individuals. Insight into this pathophysiology has led to a broader view of the clinical risk factors for hypoglycemia to include indexes of compromised glucose counterregulation and provided a framework for the study of the mechanisms of iatrogenic hypoglycemia and, ultimately, its elimination from the lives of people with diabetes.

Original languageEnglish
Pages (from-to)E1115-E1121
JournalAmerican Journal of Physiology - Endocrinology and Metabolism
Issue number6 44-6
StatePublished - 2001


  • Epinephrine
  • Glucagon
  • Sympathetic nervous system


Dive into the research topics of 'Hypoglycemia-associated autonomic failure in diabetes'. Together they form a unique fingerprint.

Cite this